TriPath's Pap slide screening tech enters US trials
This article was originally published in Clinica
Executive Summary
TriPath Imaging has begun clinical trials in the US to support a premarket approval (PMA) supplement application to use its FocalPoint slide profiler, for screening Pap smears slides, together with a location guided screening device.